GlassScriptPhysician profile
Blake Bailey Anderson
NPI 1760779458
$47,480.50
in general payments reported to CMS, 2019-2025
27 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,291 · 2020: $113 · 2021: $4,994 · 2022: $15K · 2023: $1,981 · 2024: $11K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $4,370 · Food and Beverage: $3,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,750.00 |
| Travel and Lodging | $4,370.00 |
| Food and Beverage | $3,143.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $37,670.23 | 2019-2025 | Greenlight Xps, Lumenis Pulse 120h, Lithovue |
| Lumenis, INC | $4,814.22 | 2021 | |
| Teleflex LLC | $1,983.04 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $1,762.56 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Srs Medical Systems, INC. | $145.72 | 2022-2023 | Urocuff |
| Bayer Healthcare Pharmaceuticals INC. | $144.37 | 2019-2024 | |
| Rochester Medical Corporation | $139.77 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $135.22 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $98.74 | 2021-2023 | Myrbetriq |
| Janssen Biotech, INC. | $79.99 | 2022 | |
| Abbvie INC. | $76.60 | 2021-2023 | Lupron Depot |
| Axonics, INC. | $53.50 | 2020-2023 | Axonics |
| Tempus Ai, INC | $48.64 | 2025 | Xt Cdx |
| Myriad Genetic Laboratories, INC. | $36.77 | 2024 | Prolaris |
| Dendreon Pharmaceuticals LLC | $31.95 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $31.74 | 2024 | |
| Seagen INC. | $28.47 | 2023 | Padcev |
| C. R. Bard, INC. & Subsidiaries | $25.23 | 2019-2024 | Bard Urinary Drainage Bag |
| Novartis Pharmaceuticals Corporation | $23.16 | 2022 | |
| Accord Healthcare, INC. | $21.74 | 2024 | |
| Kerecis Limited | $21.38 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ferring Pharmaceuticals INC. | $21.24 | 2024 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $20.97 | 2022 | |
| Pfizer INC. | $18.86 | 2024 | |
| Foundation Medicine, INC. | $15.95 | 2020 | |
| Koelis INC. | $15.92 | 2023 | |
| Urovant Sciences INC | $14.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.